Advertisement

chronic-disease

Allopurinol Does Not Increase Mortality in Patients With Gout & Chronic Kidney Disease

1. In patients with gout and chronic kidney disease, the initiation of allopurinol was not associated with increased mortality. 2. In patients with gout and chronic kidney disease, dose escalation of allopurinol nor achieving target serum urate levels was associated with increased mortality. Evidence Rating Level: 2 (Good) Study Rundown: Serum urate (SU) lowering medications […]

Read More

Molnupiravir does not improve clinical outcomes in patients hospitalized with COVID-19

1. Patients hospitalized with COVID-19 receiving at least one dose of molnupiravir did not show reduced mortality compared to patients receiving placebo treatment. 2. Molnupiravir was not associated with any dose-limiting side effects. Evidence Rating Level: 1 (Excellent) Study Rundown: Molnupiravir is a small molecule that interferes with the viral genome replication process in RNA […]

Read More

Neoadjuvant chemoradiotherapy demonstrates a long-term survival benefit in pancreatic cancer patients when compared to upfront surgery

1. The use of a neoadjuvant gemcitabine-based chemoradiotherapy before surgery and adjuvant gemcitabine increased the overall survival rate when compared to upfront surgery and adjuvant gemcitabine. 2. Patients in the neoadjuvant chemoradiotherapy groups had more R0 resections than patients receiving upfront surgery and adjuvant gemcitabine. Evidence Rating Level: 1 (Excellent) Study Rundown: Past randomized control […]

Read More

Betibeglogene autotemcel gene therapy effective for β-thalassemia

1. Betibeglogene autotemcel (beti-cel) gene therapy resulted in sustained hemoglobin A with a T87Q amino acid substitution (HbAT87Q) in non-β0/β0 genotype patients. 2. The gene therapy resulted in a total hemoglobin level sufficient for transfusion independence in these patients. Evidence Rating Level: 1 (Excellent) Study Rundown: β-thalassemia is caused by β-globin gene mutations, leading to […]

Read More

Semaglutide and phentermine-topiramate are effective weight reducing medications

1. GLP-1 receptor agonists, such as semaglutide, and phentermine-topiramate were shown to cause the greatest percent decrease in body weight. 2. GLP-1 receptor agonists, phentermine-topiramate, and naltrexone-bupropion were also associated with increased adverse effects. Evidence Rating Level: 1 (Excellent) Study Rundown: Over two-thirds of Americans are considered to be in the overweight or obese body-mass […]

Read More

Angiotensin II receptor type 2 and 4-stimulating antihypertensives associated with reduced long-term cognitive impairment compared to receptor inhibitors

1. This secondary analysis of the SPRINT cohort study demonstrated that type 2 and 4 angiotensin II receptor (AT2R/AT4R)-stimulating antihypertensives decreased the risk of amnestic mild cognitive impairment or probable dementia by approximately 25% compared to AT2R/AT4R-inhibiting antihypertensives. Evidence Rating Level: 2 (Good) Study Rundown: Hypertension is a well-known, highly prevalent, modifiable risk for dementia. […]

Read More

Knee extensor muscle weakness may be a risk factor for osteoarthritis

1. Low quality evidence demonstrates that knee extensor muscle weakness increased the odds of symptomatic and radiographic knee osteoarthritis in men and women. 2. In women with a previous knee injury, low quality evidence shows no association between knee extensor muscle weakness and symptomatic and radiographic tibiofemoral osteoarthritis. Evidence Rating Level: 2 (Good) Knee osteoarthritis […]

Read More

Endovascular thrombectomy 6 to 24-hours after anterior circulation stroke significantly reduces disability rates

1. Patients in the thrombectomy group reported a greater independence in daily living compared to those receiving best medical therapy alone. 2. 90-day mortality did not differ between the thrombectomy and best medical therapy groups. Evidence Rating Level: 1 (Excellent) Study Rundown: There exists extensive evidence around the use of mechanical thrombectomy for patients with […]

Read More

mRNA-1273 vaccine reduces risk of Covid-19-related outcomes compared to BNT162b2 in U.S. veterans

1. The mRNA-1273 vaccine was shown to reduce the absolute risk of Covid-19-related outcomes in U.S. veterans compared to BNT162b2 vaccine. 2. Both mRNA-1273 and BNT162b2 vaccines were shown to reduce the absolute risk of Covid-19-related outcomes in U.S. veterans. Evidence Rating Level: 2 (Good)      Study Rundown: To help combat the SARS-CoV-2 (Covid-19) pandemic, messenger […]

Read More

For latest news and updates
Email-id is invalid